PSK Pharma has registered a drug for MRI diagnosis.
PSK Pharma, a resident of Dubna SEZ, has registered a home contrast agent for magnetic resonance imaging. The new direction will expand the variety of the enterprise, which produces more than 100 medicines. The production capacity will allow the production of up to 445 thousand packages of contrast material per year.
The drug is characterized by a high concentration of solution, therefore a smaller volume of injected material is required for diagnosis. It is designed to be used in neurology, neurosurgery, oncology, mammology and cardiac angiology, as well as in pediatrics, including full term newborn screening.